Retatrutide Research Supplier — Japan

Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.

Aarise Healthcare exports Retatrutide (CAS: 2381247-90-9) to research institutions in Japan. Our WHO-GMP certified facility in India supplies 98%+ purity Retatrutide for triple GIP/GLP-1/glucagon receptor research.

Retatrutide Export Specifications for Japan

Compound	Retatrutide
CAS Number	2381247-90-9
Purity	98%+ (HPLC verified)
Form	Lyophilised powder
Regulatory Reference	PMDA
Shipping	DHL/FedEx temperature-controlled
Transit to Japan	5-10 business days
Documentation	CoA, HPLC, MS, export docs

Research Applications of Retatrutide

Retatrutide is used in triple GIP/GLP-1/glucagon receptor research. Research institutions in Japan source this compound for preclinical studies under applicable PMDA research regulations.

Why Japan Researchers Source Retatrutide from India

• WHO-GMP certified Indian manufacturer — internationally recognised compliance
• Competitive pricing for bulk research quantities
• Full export documentation package for PMDA compliance
• Temperature-controlled DHL/FedEx shipping to Japan
• Dedicated international research supply team
• 98%+ purity guaranteed with independent third-party CoA

Related Peptides in Japan

Semaglutide in Japan | Tirzepatide in Japan | Liraglutide in Japan | Mazdutide in Japan

Retatrutide — Other Countries

Retatrutide in USA | Retatrutide in UK | Retatrutide in Germany | Retatrutide in Australia

Source from India — Key Manufacturing Cities

Retatrutide in Mumbai, India | Retatrutide in Delhi, India | Retatrutide in Hyderabad, India | Retatrutide in Bangalore, India

Request Retatrutide for your Japan research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.